Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Clinical High-Risk Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Frontline Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up
Dhodapkar, Madhav V., Alsina, Melissa, Berdeja, Jesus G., Patel, Krina K., Richard, Shambavi, Vij, Ravi, Leleu, Xavier, Egan, Daniel N., Bergsagel, P. Leif, Reshef, Ran, Usmani, Saad Z, Truppel-Hartmann, Anna, Basudhar, Debashree, Thompson, Ethan, Zheng, Xirong, Eliason, Laurie, Zhong, Xiaobo, Greggio, Chiara, Tran, Sinhan, Chaudhry, Maria, Carrasco-Alfonso, Marlene J., Siegel, David S.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
P-045 Idecabtagene Vicleucel (ide-cel) in Patients (pts) With Clinical High-Risk Early Relapse Multiple Myeloma (MM) Without Front-Line (1L) Autologous Stem Cell Transplantation (ASCT): KarMMA-2 Cohort 2B
Leleu, Xavier, Chung, Alfred, Raje, Noopur, Mohan, Meera, Benjamin, Reuben, Sperling, Adam, Anderson, Larry, Dhodapkar, Madhav V., Richard, Shambavi, Truppel-Hartmann, Anna, Johnston, Sarah, Wu, Fan, Basudhar, Debashree, Thompson, Ethan, Dhanda, Devender, Eliason, Laurie, Tran, Sinhan, Chaudhry, Maria, Alsina, Melissa
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Phase 1b/2 study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer (SGNLVA-002, trial in progress)
Meisel, Jane Lowe, Pluard, Timothy J., Vinayak, Shaveta, Stringer-Reasor, Erica Michelle, Brown-Glaberman, Ursa, Dillon, Patrick Michael, Basho, Reva K, Varadarajan, Ramya, O'Shaughnessy, Joyce, Han, Hyo S., Sinha, Rajni, Fox, Jenny R., Villanueva, Rafael, Chen, Lin Chi, Wu, Sheng, Li, Hong, Tran, Sinhan, Manso, Luis
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer
Tran, Sinhan, Ready, Neal, Krug, Lee M., Pietanza, Maria Catherine, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Hoffman, Eric W., Peters, Ann-Marie, Dukelow, Karen, Bomalaski, John S., Wu, Bor-Wen, Old, Lloyd J.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase II study of the anti-ganglioside GD3 mouse/human chimeric antibody KW2871 combined with high dose interferon-a2b in patients with metastatic melanoma
Moschos, Stergios J., Tarhini, Ahmad A., Gajewski, Thomas, Scott, Andrew Mark, Lin, Yan, Shipe-Spotloe, Janice, Deblasio, Weiping Xu, Sander, Cindy, Matijevich, Karen, Smyth, Fiona Elizabeth, Liu, Zhanqi, Hoffman, Eric W., Venhaus, Ralph Rudolph, Pan, Linda S., Tran, Sinhan, Fiore, James, Kirkwood, John M.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article